Matches in SemOpenAlex for { <https://semopenalex.org/work/W1497173090> ?p ?o ?g. }
- W1497173090 endingPage "482" @default.
- W1497173090 startingPage "472" @default.
- W1497173090 abstract "Objectives: Ziconotide is often administered in combination with other analgesics via an intrathecal pump. Studies have established that ziconotide is stable when delivered alone in high concentrations. No stability data are available, however, for ziconotide given in low concentrations and/or with other analgesics as usually occurs in clinical oncology practice. The objective of this study was to assess the in vitro stability of ziconotide alone and combined with other analgesics in intrathecal pumps at 37°C, as well as in syringes at 5°C, to evaluate conditions for storing and transporting preparations. Materials and Methods: Various ziconotide concentrations (0.1, 0.25, 0.5, and 0.75 μg/mL) were combined with an admixture of ropivacaine (7.5 mg/mL), morphine (7.5 mg/mL), and clonidine (15 μg/mL) in 20-mL intrathecal pumps at 37°C and in syringes at 5°C. Solutions of ziconotide alone in concentrations of 0.25, 0.5, 0.75, and 1 μg/mL were introduced into pumps at 37°C and syringes at 5°C. Assays were performed using ultra high pressure liquid chromatography. Results: In admixtures, mean ziconotide concentrations decreased linearly to 53.4% (±3.33%) of baseline after 35 days. When ziconotide was introduced alone in pumps at 37°C, the residual concentration on day 31 was 35.54% (±0.04%) with 0.25 μg/mL, 39.37% (±0.15%) with 0.5 μg/mL, and 44.49% (±0.18%) with 1 μg/mL. Ziconotide alone or combined with the other analgesics was stable in syringes stored at 5°C. The preparations complied with the prescriptions, with a mean error of less than 10%, except with the lowest ziconotide concentration (0.1 μg/mL). Conclusions: At the low ziconotide concentrations studied, the degradation of ziconotide admixed with other drugs was linear and only weakly influenced by the baseline concentration. Linear regression with intrapolation to 30 days showed that the degradation of ziconotide admixed with other drugs was consistent with previously published data. Ziconotide is often administered in combination with other analgesics via an intrathecal pump. Studies have established that ziconotide is stable when delivered alone in high concentrations. No stability data are available, however, for ziconotide given in low concentrations and/or with other analgesics as usually occurs in clinical oncology practice. The objective of this study was to assess the in vitro stability of ziconotide alone and combined with other analgesics in intrathecal pumps at 37°C, as well as in syringes at 5°C, to evaluate conditions for storing and transporting preparations. Various ziconotide concentrations (0.1, 0.25, 0.5, and 0.75 μg/mL) were combined with an admixture of ropivacaine (7.5 mg/mL), morphine (7.5 mg/mL), and clonidine (15 μg/mL) in 20-mL intrathecal pumps at 37°C and in syringes at 5°C. Solutions of ziconotide alone in concentrations of 0.25, 0.5, 0.75, and 1 μg/mL were introduced into pumps at 37°C and syringes at 5°C. Assays were performed using ultra high pressure liquid chromatography. In admixtures, mean ziconotide concentrations decreased linearly to 53.4% (±3.33%) of baseline after 35 days. When ziconotide was introduced alone in pumps at 37°C, the residual concentration on day 31 was 35.54% (±0.04%) with 0.25 μg/mL, 39.37% (±0.15%) with 0.5 μg/mL, and 44.49% (±0.18%) with 1 μg/mL. Ziconotide alone or combined with the other analgesics was stable in syringes stored at 5°C. The preparations complied with the prescriptions, with a mean error of less than 10%, except with the lowest ziconotide concentration (0.1 μg/mL). At the low ziconotide concentrations studied, the degradation of ziconotide admixed with other drugs was linear and only weakly influenced by the baseline concentration. Linear regression with intrapolation to 30 days showed that the degradation of ziconotide admixed with other drugs was consistent with previously published data." @default.
- W1497173090 created "2016-06-24" @default.
- W1497173090 creator A5008081734 @default.
- W1497173090 creator A5038697008 @default.
- W1497173090 creator A5039062062 @default.
- W1497173090 creator A5079886038 @default.
- W1497173090 creator A5081664619 @default.
- W1497173090 creator A5089682028 @default.
- W1497173090 date "2014-07-01" @default.
- W1497173090 modified "2023-10-17" @default.
- W1497173090 title "In Vitro Stability of Low-Concentration Ziconotide Alone or in Admixtures in Intrathecal Pumps" @default.
- W1497173090 cites W1480916190 @default.
- W1497173090 cites W1530524113 @default.
- W1497173090 cites W1595876442 @default.
- W1497173090 cites W1768463275 @default.
- W1497173090 cites W190123231 @default.
- W1497173090 cites W1930291384 @default.
- W1497173090 cites W1968984411 @default.
- W1497173090 cites W1969495311 @default.
- W1497173090 cites W1981624978 @default.
- W1497173090 cites W1982744611 @default.
- W1497173090 cites W1993042107 @default.
- W1497173090 cites W2003649314 @default.
- W1497173090 cites W2011611278 @default.
- W1497173090 cites W2034384370 @default.
- W1497173090 cites W2071003827 @default.
- W1497173090 cites W2073702198 @default.
- W1497173090 cites W2084126799 @default.
- W1497173090 cites W2100964967 @default.
- W1497173090 cites W2114076964 @default.
- W1497173090 cites W2119355996 @default.
- W1497173090 cites W2120649595 @default.
- W1497173090 cites W2134986182 @default.
- W1497173090 cites W2135923112 @default.
- W1497173090 cites W2139489105 @default.
- W1497173090 cites W2151024126 @default.
- W1497173090 cites W2152791044 @default.
- W1497173090 cites W2155452679 @default.
- W1497173090 cites W2397566167 @default.
- W1497173090 cites W2408909523 @default.
- W1497173090 cites W2915405327 @default.
- W1497173090 cites W5446811 @default.
- W1497173090 doi "https://doi.org/10.1111/ner.12142" @default.
- W1497173090 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24512055" @default.
- W1497173090 hasPublicationYear "2014" @default.
- W1497173090 type Work @default.
- W1497173090 sameAs 1497173090 @default.
- W1497173090 citedByCount "21" @default.
- W1497173090 countsByYear W14971730902014 @default.
- W1497173090 countsByYear W14971730902015 @default.
- W1497173090 countsByYear W14971730902016 @default.
- W1497173090 countsByYear W14971730902017 @default.
- W1497173090 countsByYear W14971730902019 @default.
- W1497173090 countsByYear W14971730902020 @default.
- W1497173090 countsByYear W14971730902021 @default.
- W1497173090 countsByYear W14971730902022 @default.
- W1497173090 countsByYear W14971730902023 @default.
- W1497173090 crossrefType "journal-article" @default.
- W1497173090 hasAuthorship W1497173090A5008081734 @default.
- W1497173090 hasAuthorship W1497173090A5038697008 @default.
- W1497173090 hasAuthorship W1497173090A5039062062 @default.
- W1497173090 hasAuthorship W1497173090A5079886038 @default.
- W1497173090 hasAuthorship W1497173090A5081664619 @default.
- W1497173090 hasAuthorship W1497173090A5089682028 @default.
- W1497173090 hasConcept C157820659 @default.
- W1497173090 hasConcept C185592680 @default.
- W1497173090 hasConcept C2777389121 @default.
- W1497173090 hasConcept C2778399450 @default.
- W1497173090 hasConcept C2780269707 @default.
- W1497173090 hasConcept C42219234 @default.
- W1497173090 hasConcept C43617362 @default.
- W1497173090 hasConcept C71924100 @default.
- W1497173090 hasConceptScore W1497173090C157820659 @default.
- W1497173090 hasConceptScore W1497173090C185592680 @default.
- W1497173090 hasConceptScore W1497173090C2777389121 @default.
- W1497173090 hasConceptScore W1497173090C2778399450 @default.
- W1497173090 hasConceptScore W1497173090C2780269707 @default.
- W1497173090 hasConceptScore W1497173090C42219234 @default.
- W1497173090 hasConceptScore W1497173090C43617362 @default.
- W1497173090 hasConceptScore W1497173090C71924100 @default.
- W1497173090 hasIssue "5" @default.
- W1497173090 hasLocation W14971730901 @default.
- W1497173090 hasLocation W14971730902 @default.
- W1497173090 hasLocation W14971730903 @default.
- W1497173090 hasOpenAccess W1497173090 @default.
- W1497173090 hasPrimaryLocation W14971730901 @default.
- W1497173090 hasRelatedWork W2035322323 @default.
- W1497173090 hasRelatedWork W2059995385 @default.
- W1497173090 hasRelatedWork W2074484173 @default.
- W1497173090 hasRelatedWork W2127008040 @default.
- W1497173090 hasRelatedWork W2371048632 @default.
- W1497173090 hasRelatedWork W2407178312 @default.
- W1497173090 hasRelatedWork W2565086382 @default.
- W1497173090 hasRelatedWork W2754789322 @default.
- W1497173090 hasRelatedWork W3085668599 @default.
- W1497173090 hasRelatedWork W4245002115 @default.
- W1497173090 hasVolume "17" @default.
- W1497173090 isParatext "false" @default.